FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely cardiology, cardiac surgery, angiology and rehabilitation. Determine the presence of type 2 diabetes, heredity, burdened with IHD, LDL cholesterol, factor of smoking and, additionally, the presence of polymorphisms of the receptor activator gene of peroxisome proliferation PPAR-γ2 and PPAR-α and the number of affected coronary arteries at the time of manifestation of the disease. Then, calculate the discriminant function according to the original formula and, with its positive values, predict CC in patients with IHD, with its negative values, the absence of CC.
EFFECT: method makes it possible to predict the CC in patients with IHD with different coronary artery disease severity with high accuracy, which allows selecting a priority group of patients for personalized secondary prevention of adverse CC.
1 cl, 2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS WITHIN ONE YEAR AFTER A MYOCARDIAL INFARCTION BASED ON MOLECULAR GENETIC ANALYSIS | 2021 |
|
RU2767269C1 |
| METHOD OF PREDICTING RISK OF UNCONTROLLED BRONCHIAL ASTHMA IN OBESE CHILDREN | 2022 |
|
RU2805825C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE CARDIOVASCULAR EVENTS WITHIN A YEAR AFTER CORONARY ARTERY BYPASS SURGERY | 2020 |
|
RU2731305C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF ISCHEMIC HEART DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2620545C1 |
| METHOD FOR DETERMINING RISK OF CORONARY ARTERY ATHEROSCLEROSIS IN PATIENTS SUFFERING FROM DIABETES MELLITUS ACCOMPANIED BY CARDIOVASCULAR DISORDERS | 2013 |
|
RU2532521C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE | 2017 |
|
RU2682811C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES IN RESIDENTS OF CENTRAL RUSSIA BASED ON GENOTYPING OF THE rs11073891 POLYMORPHISM OF THE ANPEP GENE | 2023 |
|
RU2803636C1 |
| METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS WITHIN 12 MONTHS AFTER ELECTIVE ENDOVASCULAR MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2749485C1 |
| METHOD FOR DETERMINING THE RISK OF MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION USING GENETIC MARKERS | 2019 |
|
RU2711623C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES IN RESIDENTS OF CENTRAL RUSSIA BASED ON GENOTYPING OF THE rs755892 POLYMORPHISM OF THE DNAJB1 GENE | 2023 |
|
RU2803637C1 |
